(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...

GoodRx will pay $25 million to settle claims it shared users’ sensitive data with third parties like Meta and Google without ...

Antimicrobial resistance (AMR) is a critical global health threat, with ESKAPE pathogens — Enterococcus faecium, ...

Bismarck’s curbside bulk item pickup program, preliminarily launched in January, is now permanent. But how the city will ...

Over the past three decades, tremendous achievements have been made in the treatment of patients with multiple myeloma (MM), ...